Sarah Schram

Stock Analyst at William Blair

(2.91)
# 1,597
Out of 4,944 analysts
1
Total ratings
50%
Success rate
107.34%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Sarah Schram

Denali Therapeutics
Jan 3, 2025
Initiates: Outperform
Price Target: n/a
Current: $14.39
Upside: -